
Japan Stem Cell Trial for Spinal Cord Injury: What It Found
Key Takeaways A Japanese health ministry panel backed full approval of Stemirac, a bone marrow cell therapy, on 15 October 2026. Reported data compared 73 treated patients with 66 untreated patients, and 40 treated patients improved in motor function. Treated patients received more rehabilitation, so it’s hard to isolate the




